European Alliance for Medical and Biological Engineering & Science (EAMBES)

The European Society of Biomechanics is a member of the European Alliance for Medical and Biological Engineering & Science, EAMBES ( The mission of EAMBES is to improve health, wealth and well-being of the people by the application of medical and biological engineering and sciences. The activities of the EAMBES include promotion and lobbying efforts to advance Medical and Biological Engineering and Science education, training, accreditation, research and development. The ESB has three delegates at the EAMBES General Assembly and the communication between the organisations is coordinated by the EAMBES liaison (

As a member of the ESB, you are entitled to receive the benefits provided by EAMBES. This also includes the direct delivery of the EAMBES newsletter. While the EAMBES activities and news will continue to be summarised and passed on to you via the ESB website and newsletter, you may choose to also receive EAMBES updates directly from the Alliance. If you are not yet personally registered with EAMBES and wish to receive these monthly updates, you may fill in the EAMBES membership form at:

Communications from EAMBES

Pertinent excerpts from the EAMBES news are included below. ESB members are encouraged to visit the EAMBES website directly for full text of each news item and other related stories.


Horizon 2020 – the EU’s new research and innovation programme

On 11 December 2013, the European Commission has presented the first calls for projects under Horizon 2020. Worth more than €15 billion over the first two years, the funding is intended to help boost Europe’s knowledge-driven economy, and tackle issues that will make a difference in people’s lives.

Horizon 2020 is built around three pillars:

  1. Support for “Excellent Science” – including grants for individual researchers from the European Research Council and Marie Skłodowska-Curie fellowships (formerly known as Marie Curie fellowships);
  2. Support for “Industrial Leadership” – including grants for small and medium-sized enterprises and indirect finance for companies through the European Investment Bank and other financial intermediaries;
  3. Support for research to tackle “societal challenges”. During negotiations between the European Parliament and Council it was decided to support research towards meeting seven broad challenges.

ESB members are encouraged to read this EAMBES news item, as it provides an excellent, detailed and concise summary of Horizon 2020, with a focus on the opportunities for those active in the field biomedical engineering:

Results of the consultation on Open Research Data

On 17 October 2013, the Commission published the results of the consultation on “Open Research Data”. The consultation was aimed at facilitating access to data in the context of Horizon 2020. The report on the consultation proposed that, because of its implications on privacy and data protection, data originating from clinical trials should be excluded from the scope of the Commission’s general initiatives on Open Research Data.

Report on Medical Devices Regulation passes

On 25 September 2013, the European Parliament’s Environment, Public Health and Food Safety Committee (ENVI), voted in favor of the Draft Report on a new Medical Devices Regulation. The Report calls for stricter controls on medical devices, including a new system of pre-market approval of medical devices and enhanced traceability of devices placed on the market.

The Report has been criticised by the medical devices industry. In a press release on 25 September, the representative organisation of the majority of medical device companies in Europe stated that the Parliament’s health committee had favoured an overly complex pre-market approval system, with heterogeneous evaluation processes.

On 22 October 2013, the European Parliament approved the proposed Medical Devices Regulation, supporting the stricter legislation for the approval and marketing of medical devices. The European Parliament also introduced the creation by the EC of a new advisory group, the “Medical Devices Advisory Committee” (new article 78 a). Its role will be to provide support, advice and expertise on broad aspects of medical device regulation and in vitro diagnostics. This group provides an opportunity for EAMBES members to lend their expertise to the European Commission.

On 22 October 2013, the European Parliament also voted in plenary on the proposed In Vitro Diagnostic Medical Devices Regulation. The result was criticised by the European Alliance for Personalised Medicine, who object that the work of those engaged in genomics could be hindered.

OECD publishes Health Data 2013

The Organisation for Economic Cooperation and Development (OECD) has released a report providing comprehensive comparable statistics on health and health systems across the 34 OECD countries. This useful document includes information on many key indicators (e.g., health status, risk factors, health care resources and utilisation, pharmaceutical consumption and sales…), as well as briefing notes for 40 countries. It also contains information on health expenditure, showing how growth has slowed significantly in 2010 and 2011, due to the economic crisis. Spending grew on average by close to 5% year-on-year from 2000 to 2009, around 0.5% in 2010 and 2011 and by 0.7% 2010 and 2011.

€70 Billion package agreed for Horizon 2020

After a long negotiations between the Council of the European Union and the European Parliament, a circa €70 billion package has been agreed for Horizon 2020, the latest framework programme for research and innovation. The Horizon 2020 program meets several important demands:

  • A dedicated SME instrument to boost innovation in Europe’s businesses
  • A fast track to innovation into the programme.
  • Dedicated measures to widen participation, such as teaming and twinning initiatives, networking measures and “return grants”.
  • Synergies between Horizon 2020 and the EU Structural Funds tosupport investments in the R&D infrastructures of less-well performing regions.
  • A shortened time for grants and a reduced administrative burden.

The VPH Institute takes a stand on the Data Protection Regulation Amendments

VPH researchers working towards personalised in silico medicine in the EU fully support amendments to the LIBE (Civil Liberties, Justice and Home Affairs) Committee Report on the Data Protection Regulations, which adequately take into account the needs of public health researchers.

Access to health data is key to predicting, diagnosing and treating disease as well as for the development of new therapies to tackle old health problems. Responsible access to health data must be maintained. As such, the VPH very much welcomes the balanced approach being taken by many members of the European Parliament who have championed the interests of researchers dedicated to improving health across the EU.

EAMBES publishes a position paper on Horizon 2020

This paper titled: “EAMBES position paper for Horizon 2020 research in technologies for health and medicine: a comprehensive biomedical engineering approach for future personalized medicine and healthcare technologies” is a continuation of the Expert Policy Workshop on Biomedical Engineering at the European Parliament on March 27th 2012 hosted by the European Parliamentarian Dr Thomas Ulmer (EPP, Germany) in collaboration with EAMBES. The workshop produced ten recommendations to contribute to the current debate on European research and innovation.

With the position paper, the EAMBES aims to provide practical recommendations to Horizon 2020 calls on research in technologies for health and medicine. The specific inclusion of biomedical engineering in Horizon 2020 would do much to address the growing problems that have been identified during the Commission’s reflection process on chronic diseases and would be a step towards addressing the problems described in the Commission Communication on Active and Healthy Ageing and novel developments of personalized medicine.

Horizon 2020 Update

On 29 May 2013, the Council of the European Union’s Competitiveness Council, discussed Horizon 2020, the EU’s 8th Framework Programme for Research and Innovation. A simplification of the funding system is considered a central part of the Council’s position on the Horizon 2020. EAMBES has published a position paper on Horiozn 2020, which aims to promote Biomedical Engineering, its approaches and above all, highlights its potential for Europe on Horizon 2020. After a long negotiations between the Council of the European Union and the European Parliament, a circa €70 billion package has been agreed for Horizon 2020, the latest framework programme for research and innovation.

Commission Report Reveals Significant Gender Imbalance in Research

The European Commission’s DG Research has published a report entitled “She figures: Gender in Research and Innovation 2012”, which shows that despite the fact that more women than men are graduating, women comprise only 20% of senior academics in Europe’s Universities. Key figures which emerged from there report indicated that:

  • In 2010, the share of women in total employment reached 45 %, but women made up 53 % of tertiary educated people who were employed as professionals or technicians. However, that same year in the EU-27, only 32 % of scientists and engineers were women.
  • In 2009, in the EU-27, women in research remained a minority, accounting for only 33 % of researchers.
  • In 2010, in the EU-27, 46 % of all PhD graduates were women. Over the period 2002–2010, the average number of female PhD graduates increased at a rate of 3.7 % per year, compared to 1.6 % for male PhD graduates

Medical Devices Regulation – Draft Report Published

The Draft Report on the proposal for a Regulation on medical devices was published on 15 April 2013. The Draft Report was prepared and drafted by Ms Dagmar Roth-Behrendt MEP, rapporteur for the Environment, Public Health and Food Safety (ENVI) Committee, which is the lead Committee for the dossier in the European Parliament. Ms Roth-Behrendt MEP prepared the Draft Report after hearing the interested parties in two stakeholder meetings (a public hearing organised by the ENVI Committee and a workshop organised by the S&D) and an exchange of views organised in the ENVI Committee. On 29 May 2013, the Environment, Public Health and Food Safety (ENVI) Committee, the Committee responsible for the Medical Devices Regulation, met to discuss and publish amendments to the text.

European Parliament Hosts Workshop on Medical Devices Regulations

On 19 March 2013, the Socialist and Democrats (S&D) Group in the European Parliament organised a workshop on Medical Devices, which was organised by the Rapporteur for the Medical Devices Regulation proposal, Ms Dagmar Roth-Behrendt (S&D, Germany). The main discussion topics were the pre-market authorisation versus post-market surveillance improvements, a decentralized versus a centralised system and the performance of notified bodies.

New Marie-Curie Grants Now Available

The European Commission is inviting bids for the final tranche of the Marie Curie fellowship grants allotted under the current 7th Framework Programme for Research and Innovation.

Over 227 million euro, the highest single amount made available through the Marie Curie Actions fund will be awarded to around 1000 researchers this year. The application process will run until 14 August 2013.

EAMBES New Council Members Elected

Seven candidates run for the 2013 Council elections:


  • Prof Dr Andreas Lendlein, representative of the Center for Biomaterial Development, Institute of Polymer Research, Helmholtz
  • Prof Timo Jämsä, representative of University of Oulu, Finland


  • Dr A.C. Linnenbank, representative of the Netherlands’ Society for Biophysics and Biomedical Engineering
  • Univ Prof DI Heinrich Schima, representative of the European Society for Artificial Organs and the Austrian Society for Biomedical Engineering
  • Prof P A Kyriacou, representative of IPEM Institute of Physics and Engineering in Medicine

Two from the Division of Fellows:

  • Emeritus Prof. Joseph Cyril Barbenel
  • Prof Dan Adam

It is with great pleasure that EAMBES announces that all the candidates are formally elected members of the Council of the Alliance. They join the four candidates elected in 2012:

  • Prof Jari Hyttinen – Finnish Society for Medical physics and Biomedical Engineering
  • Prof Birgit Glasmacher – European Society for Artificial Organs
  • Prof Damien Lacroix – European Society of Biomechanics
  • Prof Michael Imhoff – DGBMT German Society for Biomedical Engineering within VDE e.V

European Parliament Hosts Medical Devices Workshop

On 26 February 2013, a hearing was organised by the Environment, Public Health and Food Safety (ENVI) Committee of the European Parliament to discuss the Commission’s proposals for a Medical Devices Regulation and for an In-Vitro Diagnostic Medical Devices Regulation. The focus of the discussions between a large number of policy makers and stakeholders was on the reprocessing of medical devices and on the qualification of notified bodies.

European Doctoral Academy in Regenerative Engineering

Thirteen Doctoral Fellowships in 6 European Institutions collaborating in a new FP7-PEOPLE Marie Curie Initial Training Network (ITN): TECAS (Tissue Engineering Solution for Cardiovascular Surgery). TECAS-ITN is looking to recruit 13 ESR Fellows, with backgrounds ranging from physical sciences and engineering to life sciences and medicine, who will follow a cross-disciplinary and inter-sectorial research training programme in the field of cardiovascular tissue engineering and regenerative medicine.

DISCIPULUS: the Public Revision of the Roadmap Kicks Off

Public discussion of the research roadmap for the Digital Patient has been recently kicked off, as part of the DISCIPULUS project. The Digital Patient is envisaged as a sophisticated computer program that will be capable of generating a virtual living version of an individual. The roadmap aims to be the collegial expression of our community’s views, and this will be possible only if a large group will contribute to discuss and orient the roadmap content.

While DISCIPULUS is a support action funded by the European Commission, as it is usual for the VPH community, the debate that will bring to the finalisation of the roadmap is open to every interested stakeholder, European or International.

Report of the 2012 Activities of the Alliance

2012 was particularly fruitful for many different reasons: the great work carried out by the Policy Affairs Work Group which made possible to hold an EAMBES meeting at the Parliament; the creation of the Division of Fellows and the formal establishment of the relationship between EAMBES and IFMBE, to name only a few. For more information read the full document.

VPH Institute Position Statement on Animal Experimentation

The Virtual Physiological Human (VPH) Institute for Integrative Biomedical Research (VPH Institute) recently produced a position statement on animal experimentation. The position statement supports the thesis that the virtual modelling technologies provided by the VPH can be applied to animal experimentation and help reducing the number of animals used. In silico research provides enormous potential advantages for reducing, refining and replacing animal testing as well as translating the results of animal experimentation to humans. The existing and future benefits that will be brought by the VPH require a long-term support from European and national institutions to generate coherent and coordinated scientific progress in this area.

Winter 2012:

Commission launches consultation on Future and Emerging Technologies

The European Commission has launched a public consultation on “Directions for Future and Emerging Technologies Research”. The aim of the consultation is to get ideas from stakeholders on “game-changing” directions for future research in Horizon 2020.

Future and Emerging Technologies (FETs) fall under Part 1 of the Horizon 2020 dossier (Excellence in Science), which is currently being discussed in the European Parliament and Council. The goal of this section is to foster radically new technologies by exploring novel and high-risk ideas building on scientific foundations. FET calls for proposals in Horizon 2020 which will likely be launched in 2014. Call content will be heavily based on this consultation, therefore the EAMBES efforts to promote biomedical research will have clear benefits for ESB members.

EC publishes Communication on international cooperation in research and development

The European Commission published a Communication entitled “Enhancing and focusing EU international cooperation in research and innovation: A strategy approach”. This document recognises that research and innovation are increasingly interlinked internationally and calls for measures to increase cooperation with countries outside the EU in this regard. The Communication stresses that the Union must promote itself as an attractive location for carrying out research, in order to remain a competitive global player. The Communication makes many references to Horizon 2020 and other EU funding mechanisms. This communication is in line with EAMBES’ goals, as it contains language that promote policies which facilitate research across borders, particularly in Horizon 2020. For researchers who are members of the ESB, any efforts to promote international cooperation are also in our interest.

Medical Device Regulation now published

The proposals for the new Medical Device Regulation (including both medical device and active implantable medical devices) and for the new Regulation on In-Vitro Diagnostic Medical Devices have been published by the European Commission. Both documents will now enter the parliamentary discussion phase. The importance of this discussion phase, and the impact of lobbying, should be emphasized, as further changes are expected during parliamentary discussion. The proposed legislation will directly affect research with medical devices (“investigational devices”) and how biomedical research can be translated into medical devices for patient care. Many researchers in the biomechanics community will also be directly affected by changes to this legislation, therefore it is important to remain informed on this process and to consider carefully a personal input to the discussion. The EAMBES appreciates any further feedback and input on this matter at any time. Prof Michael Imhoff, the EAMBES Councillor for Regulatory & Industrial Affairs, is directly dealing with this topic and can be reached via the contact information on the EAMBES webpage.

Call for Bids VPH2014

The VPH Institute has opened the call for bids to host the next VPH conference in 2014. Interested organisations should submit their bid by January 13th, 2013. The International Conference on the Virtual Physiological Human is a conference series held biennially on even years, with the objective to provide a forum for the discussion and the dissemination of the broad field of in silico medicine. Each conference is organised by a local committee, selected through a public bid by the Board of Directors of the VPH Institute. Given the close integration of many ESB members into VPH projects, this is an excellent opportunity to promote our society and our members’ research.

The European Research Council publishes its 2013 “Ideas” work programme

The European Research Council (ERC) has published their “ideas” work programme for 2013. The aim of the ERC is to foster the development of European research and improve the attractiveness of Europe for researchers from all over the world with the goal of making Europe an attractive area for leading researchers. The ERC is promoting interdisciplinary research, with the sole criterion for funding being “excellence in science”. The programme will fund independent researchers at any career stage through four frontier research grants: Starting, Consolidator, Advanced, Synergy Grants. These grants are designed to fund teams of researchers who wish to engage in high-risk frontier science, and a strong track record of the applying individual or group is essential. While Biomedical Engineering is not specifically mentioned, there is an emphasis on cross disciplinary research and aspect of biomedical sciences, therefore the broad nature of the programme makes it attractive for proposals on Biomechanics/Biomedical Engineering.

The full work programme description is available via the link on EAMBES site.

Horizon 2020 research to be public

The European Commission has announced plans to make open access to scientific publications a general principle of Horizon 2020. Articles should be either immediately accessible online by the publisher or researchers should make their articles available through an open access repository. Open access publication costs will be eligible for reimbursement by the European Commission. The Commission will targets of 60% of European publicly-funded research articles to be available under open access by 2016.

Commission Includes Biomedical Engineering in FP7 2013 Work Programme

The Directorate for Research and Innovation of the European Commission published its work programme for 2013. In the programme, specific reference is made to “biomedical engineering” (section 1.2, Biotechnology, generic tools and medical technologies for human health), with a focus on imaging technologies for guiding therapeutic interventions for personalised medicine applications. Additionally, there are many references to “biomedical devices”, with a specific section (FP7-HEALTH-2013-INNOVATION-1) called “Innovative approaches to address adverse immune reactions to biomedical devices, implants and transplant issues”.

The full work programme can be accessed via the EAMBES link.

Fall 2012:

Expert Policy Workshop on Biomedical Engineering

On March 27th, 2012, the European Parliament hosted an Expert Policy Workshop on Biomedical Engineering in collaboration with EAMBES. The clear outcome of the workshop was that Biomedical Engineering needs a formal recognition at the EU level. The European Parliament would like to ensure that this need becomes a reality to guarantee future financial support. Specifically, the multi-disciplinary and translational strengths of Biomedical Engineering were highlighted, and a strong role was promoted in the context of growth, health and well-being. Specific recommendations and the full report are available from the EAMBES website.

Revision of Medical Devices Legislation

Publication of the European Commission proposals for a revision of the medical devices legislation has been pushed back. In light of recent high-profile reports of implant risks and failures (e.g. the PIP breast implant scandal), the EC has conducted test scenarios to determine whether or not similar cases could arise, and how to increase patient safety and market surveillance. Discussions have shown a general agreement on key issues such as increased traceability, the creation of national and/or EU implant registries, pre- and post-market assessments and stricter rules for Notified Bodies. The inclusion of Clinical Investigations before receiving a CE mark for a medical device remains a controversial point. EAMBES is closely monitoring the new Medical Device Directive, and welcomes any feedback directly to Prof. Michael Imhoff, the Councillor for Regulatory & Industrial Affairs. As a further example of the EC’s desire to establish stronger, evidence-based support for implant performance (or non-performance), the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) is currently gathering information to issue a scientific opinion on the safety of metal-on-metal joint replacements, with a focus on hip implants.

Interview with Damien Lacroix

Prof. Damien Lacroix, representative and past-president of the European Society of Biomechanics, was nominated Councillor for Communication of the EAMBES. In a short interview, Damien provides an introduction to his involvement in BME and his plans to contribute to the future of the EAMBES.

Horizon 2020

On June 18th, 2012, the European Parliament’s Industry, Research and Energy Committee (ITRE) held a debate on Horizon 2020 and the European Institute of Innovation and Technology (EIT). Discussion topics included the need to promote excellence in research, to have open access to research results and transparency in the progress and status of research results. There was a general consensus that Horizon 2020 did not have a sufficient focus on health. Multiple references to biomedical research in the Parliament’s report underline that health research needs to be better coordinated, also the use of technological and infrastructural resources across the entire biomedical community. The definition of biomedical research and promotion of translational research by a high-level scientific advisory board was a key recommendation. Horizon 2020 is expected to be adopted by the European Parliament in late 2013.

European Research Area

On July 17th, 2012, the European Commission published a Communication on “A Reinforced European Research Area Partnership for Excellence and Growth”. The Commission seeks to reduce the brain drain and the wide regional differences in research and innovation performance, aiming at excellence across the EU through coordinated and effective specialisation. Key priorities are the improvement of national research programs, the promotion of transnational cooperations – including removing barriers to the exchange of researchers – and the open distribution of scientific knowledge. Related to this, the European Commission announced its plans to make open access to scientific publications a general principle of Horizon 2020. The full EC communication is available via the EAMBES website.

Further news items are available at the EAMBES website.

Spring 2012:

EAMBES General Council Elections

In February, the EAMBES held a new round of elections to select the society representatives to the General Council. The ballots closed on 28 February, 2012 and the following new members were elected to the Council: Birgit Glasmacher, Jary Hyttinen, Damien Lacroix and Michael Imhoff.  The revitalised council is now complete and the ESB is well represented in this body.

EAMBES General Assembly

The EAMBES held their General Assembly on 13 March, 2012 in Brussels, with attendance by the EAMBES Council and 18 additional representatives of societies and institutions. The General Assembly continues to strongly support the lobbying activities of the EAMBES.

Innovation Pathway: Bridge to Clinic

In its recent newsletter, the EAMBES highlights the efforts of the FDA to promote biomedical engineering and a faster market access for medical devices, a topic that is at the top of the priority list for the EAMBES’s discussions with EU policy makers. With the FDA “Innovation Pathway 2.0”, the aim is to shorten the time to develop medical products through an earlier collaboration of FDA staff with the innovators. These developments are encouraged by the US administration. In contrast, the policy and future perspective in the EU is less clear. As one of many members of the ESB who is also heavily involved in biomedical engineering activities and the development of new medical technologies, I find it encouraging that the EAMBES continues to push for support at the European level for translational research and a less restrictive path-to-market.

FP7 and Beyond

The EAMBES continues to fulfil its role of monitoring and informing on the progress towards comprehensive funding within the upcoming 2012 FP7 funding programme (and beyond) for research in the domain of biomedical engineering. It is encouraging to see that there are still openings being created, however some creativity may be required for the “classical” biomechanist to fit the profile presented in the current draft of the upcoming Health Work Programme.

Fall 2011:

EAMBES branded event at the parliament!

On March 27th, 2012 the Member of the European Parliament Thomas Ulmer will host an Expert Policy Workshop organized with the collaboration of EAMBES.
Read the full article:

EAMBES contributes to the seminar “Medical Technologies – Solutions to the grand societal challenge of healthy ageing”

A follow-on meeting to the Munich Round Table on Medical Technology was organized in Brussels on November 24th, 2011 with the aim of increasing research support for our field. Read the full article:

Horizon 2020 is now public

On November 30th the European Commission published the proposal package for the for next EU Framework: Horizon 2020.
Read the full article:

A short interview with the Councillor for External Relationships: Prof. Christopher James

At the last General Council election, the representative of IEEE EMBS Europe Christopher James, was nominated Councillor for External Relationships of the Alliance. Read the full article:

Re-cast of the Medical Devices Directives

Latest information on the current status of the revised directives indicate that the draft proposal is likely to be available for consideration by the European Parliament and a working party of member states in the second quarter of 2012. A primary objective of the initiative is to provide a simple and easily-understandable regulatory environment for medical devices. One issue that has been highlighted during the initial consultation period is the challenge posed by new and emerging technologies and a shortage of essential expertise. EAMBES welcomes the views of members with a specific interest in regulatory issues. If you wish to contribute, please contact the EAMBES Manager (

Forthcoming Events

This is an updated calendar of major events organised within the Biomedical Engineering Community in Europe:

State of the Alliance 2011

On the occasion of the campaign for the membership renewal, Marco Viceconti, President of the Alliance, makes a summary of the activities undertaken during the past year.
Read the full article:

EAMBES establishes the Division of Fellow

At the last Council meeting, the Councillor for Academic Affairs, Maria Siebes presented a proposal to activate the Division of Fellows, an essential component of the EAMBES Statute that was never initiated.
Read the full article:

From National to European

EAMBES is working hard to increase awareness in the European Commission and Parliament of the potential of Biomedical Engineering to address the key societal challenges that have been set.
Read the full article:

The European Commission’s possible recognition of Biomedical Engineering brings hopes

Well informed sources suggest that Biomedical Engineering will be amongst the focus disciplines of the European Commission’s “Working Paper for Health Research in 2013”.
Read the full article:

A short interview with the Councillor for Regulatory and Industrial Affairs: Patricia Lawford

At the last General Council election, Patricia Lawford, the representative of University of Sheffield (United Kingdom) was nominated Councillor of the Regulatory and Industrial Affairs of the Alliance.
Read the full article:

The EAMBES General Council met in Budapest on September 16th 2011

The second annual meeting of the reformed General Council of EAMBES took place in Budapest during the 5th European Conference of the IFMBE.
Read the full article:

Call for Nomination for the 2012 EAMBES Council Election

The Call for Nominations officially opened on the 1st of October 2011 and will last to the end of the month.
Read the full article:

The EAMBES Policy Affairs Working Group (PAWG) opens its activities to the membership

During the recent General Council meeting, it was decided that the future PAWG conference calls will be open to the delegates of the member organisations who wish to be closely involved in the Policy Affairs initiatives.
Read the full article:

Consultation on the ERA Framework: Areas of untapped potential for the development of the European Research Area (ERA)

This public consultation aims at gathering views and evidence from stakeholders on the key obstacles which have to be tackled to achieve a well-functioning ERA.
Read the full article: